Transgenic Animals Market Revenue to Attain USD 9.11 Bn by 2033

06 Oct 2025

Share :

Table of Content

1. Transgenic Animals Market Revenue and Trends 2025 to 2033 2. What Is Fueling Expansion in the Transgenic Animal Industry? 3. Segmental Analysis 4. Regional Analysis 5. Transgenic Animals Market Coverage 6. Key Players Transgenic Animals Market

Transgenic Animals Market Revenue and Trends 2025 to 2033

The global transgenic animals market revenue reached USD 4.10 billion in 2025 and is predicted to attain around USD 9.11 billion by 2033 with a CAGR of 10.51%. The transgenic animal market is driven by advancements in genetic engineering, expanding biomedical research, and increasing applications in disease modeling and therapeutic development.

What Is Fueling Expansion in the Transgenic Animal Industry?

The transgenic animal industry is experiencing growth driven by increased global demand for cutting-edge biomedical research, the production of therapeutic proteins, and genetically engineered animal models in the study of human disease. Transgenic animals are organisms whose genomes are modified to contain genes from other organisms, and enhancements to agriculture. The transgenic animal industry is growing due to increased applications in drug discovery, biotechnologies, and livestock improvement. It will likely become an important contributor to innovations in both medicine and agriculture around the world.

Segmental Analysis

• By Animal Type- The predominance of mice is due to their genetic proximity to humans, rapid reproduction rate, and their use in understanding disease processes and testing therapeutic interventions.
• By Technology - CRISPR-Cas9 is the leading technology, and allows high precision, high efficiency, and low cost genome editing features which have rapidly advanced the production of transgenic animals for specific and relevant studies.
• By Application- Biomedical research and gene applications are the most common, as transgenic animals are necessary to study disease pathway's, the validation of drug targets, and the study of highly complex genetic functions.
• By End User - Biotechnology and pharmaceutical companies are the major end users of transgenic animal models as they utilize them in drug discovery, toxicity testing, and in preclinical development of new therapies.

Regional Analysis

North America is the major region involved in the transgenic animal market due to its sophisticated biomedical research infrastructure, robust pharmaceutical pipelines, and extensive levels of government and institutional support. The region is home to a collision of laboratories, universities, and biotechnology companies using genetically modified organisms in drug discovery, toxicology evaluations, and disease modelling; therefore solidifying its status as the major region.

The Asia Pacific region is one of the fastest growing areas for the transgenic animal market due to the growing biotechnology clusters in China and India, along with greater research funding, academic–industry partnerships, and increased government support. Moreover, with generally lower development costs and the increased desire for innovations in therapy development, Asia Pacific region has emerged as the fastest growing area for the application of genetic technology in animals.

Transgenic Animals Market Coverage

Key Players Transgenic Animals Market

• Charles River Laboratories 
• The Jackson Laboratory 
• Taconic Biosciences 
• Envigo (now part of Inotiv) 
• GenOway 
• Cyagen Biosciences 
• Hera BioLabs 
• PolyGene AG 
• Creative Biolabs 
• Applied StemCell, Inc. 
• Biocytogen 
• Crown Bioscience (Jiangsu Hengrui Medicine subsidiary) 
• Harbour BioMed 
• GENEWIZ (Azenta Life Sciences) 
• TransViragen 
• Corning Incorporated (animal models & research division) 
• Horizon Discovery (PerkinElmer) 
• Inotiv Inc. 
• Ozgene Pty Ltd 
• SAGE Labs (part of Horizon Discovery) 

Recent Developments

• In July 2025, Biocytogen Pharmaceuticals expanded its portfolio with advanced genetically engineered animal models and enhanced preclinical services, including efficacy studies, PK/PD analysis, biomarker assessment, and non-GLP toxicology testing. (Source: https://www.businesswire.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6933

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344